3Vote!
Medical News Today (Free subscription) | 12 hours ago
Last week during the 'Vaccines for Biothreats and Emerging and Neglected Diseases Symposium' in Galveston TX, USA, the Elsevier journal Vaccine released a supplement dedicated to vaccines for biodefense. This publication provides a comprehensive, state-of-the-art overview on vaccines that have been developed against a diverse group of human and veterinary pathogens, including Bacillus anthracis, smallpox,...
5Vote!
Fast Company (Free subscription) | yesterday
UPDATE: A FDA advisory panel has ruled that Protein Sciences' insect cell-based flu vaccine requires more safety tests before being made commercially available in the U.S. The panel said the vaccine appeared to be as safe and effective as more traditional egg-based flu vaccines, but there were concerns over a few patients who had adverse responses, according to Bloomberg . The FDA isn't required to...
+Vote!
Merv Sheppard's Transplant Network (Free subscription) | 5 hours ago
For anyone avoiding getting the H1N1 flu shot because of concerns about potential side effects this briefing from the World Health Organization is certainly great news. The WHO says that all data compiled to date indicate that pandemic vaccines match the excellent safety profile of seasonal influenza vaccines, which have been used for more than 60 years. Read the full WHO briefing on the Safety of...
5Vote!
Examiner (Free subscription) | yesterday
Babies squirmed and wailed as needles plunged into their chubby thighs at a public health clinic on the outskirts of Hanoi on Friday. Like little ones everywhere, the reaction to the sting was never pretty.
5Vote!
Seattle Times (Free subscription) | yesterday
Babies squirmed and wailed as needles plunged into their chubby thighs at a public health clinic on the outskirts of Hanoi on Friday. Like little ones everywhere, the reaction to the sting was never pretty.
4Vote!
PR News Wire (Free subscription) | yesterday
PRINCETON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax(TM) and other rapidly acting vaccines. Soligenix received a $9.4 million grant from the National Institute...
5Vote!
Business Wire (Free subscription) | yesterday
SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets. In addition, ferrets immunized with Inovio’s...
3Vote!
Medical News Today (Free subscription) | yesterday
Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that the company's SynCon™ Chikungunya virus DNA vaccine induced protective neutralizing antibody responses in a preclinical non-human primate model. Dr. David B.
3Vote!
Pat Sullivan Blog (Free subscription) | 11/20/2009
Dr. Russell Blaylock, a retired neurosurgeon and writer of the Blaylock Wellness Report does not like the Swine Flu Vaccine. I had the good pleasure a few years ago, to have dinner with Dr. Blaylock. A very reasonable and very smart guy. He said the following in his most recent Newsletter: "No one should take the swine flu vaccine – it is one of the most dangerous vaccines ever devised....
3Vote!
Avian Flu Diary (Free subscription) | 11/19/2009
# 4046 While it sounds like something out of a science-fiction novel, researchers have spent years working on a new way to manufacture influenza vaccines by inserting genetically engineered pieces of the influenza virus into caterpillar cells. The promise of this cell-based manufacturing technique is that it can produce vaccine in 1/3rd the time of the traditional egg-based technology; in as little...
4Vote!
PandemicFlu.gov (Free subscription) | 11/19/2009
To date, WHO has received vaccination information from 16 of around 40 countries conducting national H1N1 pandemic vaccine campaigns.
3Vote!
Radon Mitigation Pittsburgh (Free subscription) | 2 hours ago
( EMAILWIRE.COM , November 21, 2009 ) Dallas, TX - BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) plunges 8.17% to $9.55 after the company yesterday announced pricing of a public offering of 5,000,000 shares of its common stock at $9.75 per share, resulting in gross proceeds of $48.75 million. All of the shares are being offered by BioCryst pursuant to an effective shelf registration statement previously...
3Vote!
LifeBridge Health Blogs (Free subscription) | yesterday
I was recently interviewed by Philip and Lisa Mulford for this week's episode of their audio show, Communication 360 . From the episode description : Every day [swine flu] is in the news, often with conflicting information. Even the medical community is inconsistent. So what do you do? And more importantly what is the best decision for your child? Having already experienced the H1N1 with both their...
4Vote!
MediaBistro.com (Free subscription) | yesterday
Little, Brown has just released an eBook-only update of the print title , "The Vaccine Book: Making the Right Decision for Your Child"--an instantaneous publishing response to public concerns about H1N1 flu (or Swine Flu) vaccines. To find out more about how eBooks can help medical publishing, GalleyCat interviewed the book's author, Robert Sears , M.D., about the digital addition. He hoped...
+Vote!
Avian Flu Diary (Free subscription) | yesterday
# 4054 The WHO (World Health Organization) has issued a statement about the recently announced mutation in the H1N1 virus out of Norway. For now, the WHO states that the mutation is not widespread in Norway, and the significance of these changes is difficult to assess . This may well turn out to be a tempest in a teapot , and end up more of a scientific side-show than anything else, but any genetic...
4Vote!
bharatbook | 11/12/2009
Bharatbook.com included a new report on "Global Vaccine Market Forecast to 2012" which gives an extensive and objective analysis on the global vaccine market. Global Vaccine Market Forecast to 2012 Vaccines have emerged as one of the most lucrative segment in the global pharmaceutical industry. With a projected CAGR of over 13% during 2009-2012, the industry will emerge as the fastest growing therapy
5Vote!
obi jo | 11/06/2009
http://benkazie.wordpress.com/2009/11/05/sebelius-administration-blamed-for-dearth-of-h1n1-vaccines/ Indeed, one cannot blame the President or Administration for every aspect of the recent swine flu vaccine saga. To be sure there are technologic hurdles that have had to be overcome and remain a source of difficulty. Specifically this relates to the decades old technique of producing vaccine from virus...
3Vote!
helenely1 | 11/03/2009
We should consider the swine flu more seriously than a cold since any flu is always a highly contagious disease caused by a virus. Young children, pregnant women and people with respiratory problems are more liable to be infected by the flu influenza, especially when they have not been vaccinated against a new virus that has just mutated. Every year the regular flu kills 36 , 000 people in America